Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells

Toxicology Mechanisms and Methods

Volumn 20, Issue 5, 2010, Pages 234-241

  Wang, Yao ^a   Yang, Zehong ^a   Zhao, Xiaojun ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Apoptosis; Combination schedule; Cytoplasmic vacuolization; Honokiol; Paraptosis

Indexed keywords

COLLAGEN TYPE 1; FIBRONECTIN; HONOKIOL; IMATINIB;

APOPTOSIS; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL ADHESION; CELL MEMBRANE; CELL PROLIFERATION; CELL STRAIN K 562; CELL SWELLING; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; ENDOPLASMIC RETICULUM; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULAR INTERACTION; MONOTHERAPY; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; BIPHENYL COMPOUNDS; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; DRUG ADMINISTRATION SCHEDULE; DRUG SYNERGISM; HUMANS; LEUKEMIA; LIGNANS; PIPERAZINES; PYRIMIDINES; VACUOLES;

MAGNOLIA;

EID: 77952816915     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376511003758831     Document Type: Article

References (25)

1. Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB. 2006. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res 4:621-633.
2. Barone C, Landriscina M, Quirino M, Basso M, Pozzo C, Schinzari G, Di Leonardo G, D'Argento E, Trigila N, Cassano A. 2007. Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial. Br J Cancer 96:21-28.
3. Battle TE, Arbiser J, Frank DA. 2005. The natural product honokiol induces caspase-dependent apoptosis in B-cell chronic lymphocytic leukemia (B-CLL) cells. Blood 106:690-697.
4. Bharti AC, Takada Y, Shishodia S, Aggarwal BB. 2004. Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism. J Biol Chem 279:6065-6076.
5. Bursch W, Ellinger A, Gerner C, Frohwein U, Schulte-Hermann R. 2000. Programmed cell death (PCD). Apoptosis, autophagic PCD, or others? Ann N Y Acad Sci 926:1-12.
6. Chou TC, Motzer RJ, Tong Y, Bosl GJ. 1994. Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design. J Natl Cancer Inst 86:1517-1524.
7. Chou TC, Talalay P. 1984. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 22:27-55.
8. Das Gupta S, Debnath A, Saha A, Giri B, Tripathi G, Vedasiromoni JR, Gomes A. 2007. Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562. Leuk Res 31:817-825.
9. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB. 1996. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561-566.
10. Herrera-Gayol A, Jothy S. 1999. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness. Exp Mol Pathol 66:99-108.
11. Ishitsuka K, Hideshima T, Hamasaki M, Raje N, Kumar S, Hideshima H, Shiraishi N, Yasui H, Roccaro AM, Richardson P, Podar K, Le Gouill S, Chauhan D, Tamura K, Arbiser J, Anderson KC. 2005. Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis. Blood 106:1794-1800
12. Jing Y, Wang L, Xia L, Chen GQ, Chen Z, Miller WH, Waxman S. 2001. Combined effect of all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia cells in vitro and in vivo. Blood 97:264-269.
13. Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenabeele P, Zhivotovsky B, Blagosklonny MV, Malorni W, Knight RA, Piacentini M, Nagata S, Melino G. 2005. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 12(Suppl 2):1463-1467.
14. Le Grimellec C, Lesniewska E, Cachia C, Schreiber JP, de Fornel F, Goudonnet JP. 1994. Imaging of the membrane surface of MDCK cells by atomic force microscopy. Biophys J 67:36-41.
15. Li L, Han W, Gu Y, Qiu S, Lu Q, Jin J, Luo J, Hu X. 2007. Honokiol induces a necrotic cell death through the mitochondrial permeability transition pore. Cancer Res 67:4894-4903.
16. Litzow MR. 2006. Imatinib resistance: obstacles and opportunities. Arch Pathol Lab Med 130:669-679.
17. Majno G, Joris I. 1995. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3-15.
18. Okada H, Mak TW. 2004. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer 4:592-603.
19. Parpura V, Fernandez JM. 1996. Atomic force microscopy study of the secretory granule lumen. Biophys J 71:2356-2366.
20. Perez-Caro M, Gutierrez-Cianca N, Gonzalez-Herrero I, Lopez-Hernandez I, Flores T, Orfao A, Sanchez-Martin M, Gutierrez-Adan A, Pintado B, Sanchez-Garcia I. 2007. Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice. Oncogene 26:1702-1713.
21. Schindler T, Bornmann W, Pellicena P, Miller WT, Clarkson B, Kuriyan J. 2000. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 289:1938-1942.
22. Silva Filho FC, Ortega-Lopez J, Arroyo R. 1998. YIGSR is the preferential laminin-1 residing adhesion sequence for Trichomonas vaginalis. Exp Parasitol 88:240-242.
23. Sperandio S, de Belle I, Bredesen DE. 2000. An alternative, nonapoptotic form of programmed cell death. Proc Natl Acad Sci USA 97:14376-14381.
24. Sperandio S, Poksay K, de Belle I, Lafuente MJ, Liu B, Nasir J, Bredesen DE. 2004. Paraptosis: mediation by MAP kinases and inhibition by AIP-1/Alix. Cell Death Differ 11:1066-1075.
25. Walsh GM, Dewson G, Wardlaw AJ, Levi-Schaffer F, Moqbel R. 1998. A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. J Immunol Methods 217:153-163.